EUVIMEDEUVIMED entdecken
Crossref

Loss of GPR146 decreases plasma levels of HDL cholesterol via post-translational up-regulation of SR-B1 protein levels

Boyan Zhang iD, Natalia Loaiza, Antoine Rimbert, Federico Oldoni iD, Lisanne L Blauw, Patrick C N Rensen, Laurent O Martinez, Jerome Robert, Arnold von Eckardstein iD, Justina Clarinda Wolters, Nicolette Huijkman, Niels Kloosterhuis und 4 weitere

Cardiovascular Research · 2026

DOI: 10.1093/cvr/cvaf254 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, 2026. Verfasst von Boyan Zhang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, Groningen 9713 AV, The Netherlands. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Cholesterol, HDL, Scavenger Receptors, Class B, Hepatocytes. Die Arbeit nennt 77 Literaturangaben. Gefördert von: China Scholarship Council and University Medical Center Groningen, Agence Nationale de la Recherche, ZonMw.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

In humans, reduced G-protein coupled receptor 146 (GPR146) expression is associated with reductions in both LDL and HDL cholesterol. While the effects on LDL cholesterol are mediated via the intracellular ERK/SREBP2 pathway, the mechanism explaining how GPR146 affects HDL cholesterol levels remains to be unravelled. Methods and results Whole-body (Gpr146−/−) and liver-specific Gpr146 knockout (Gpr146 LKO) mice were used to explore changes in HDL metabolism. Wild-type mice were treated with a MEK1 inhibitor to block ERK signalling. HDL uptake and post-translational modification of scavenger receptor class B1 (SR-B1) were studied in murine primary hepatocytes. Genetic variants in GPR146 and SCARB1 served as instruments to examine HDL size and composition in human cohort studies. Investigation in both Gpr146−/− and Gpr146 LKO mice revealed a 20% reduction in HDL cholesterol and a concomitant 30% increase in hepatic SR-B1 protein (without changes in Scarb1 mRNA). This increase was driven by a 2.2-fold increase in cell surface SR-B1 via a mechanism that appears independent of ERK. In vitro studies show that loss of GPR146 increases SR-B1-mediated selective uptake of HDL lipid and HDL protein. Consistently, carriers of a GPR146 variant associated with loss-of-function and carriers of SCARB1 gain-of-function variant share reductions in apoA-I, HDL particle size, HDL cholesterol, and cholesteryl ester content compared to non-carriers.

Conclusion

This study suggests that loss of GPR146 reduces HDL cholesterol via post-translational up-regulation of hepatic SR-B1 via an intracellular pathway that remains to be resolved. These findings imply that GPR146 inhibition to treat hypercholesterolaemia may not only lower plasma levels of LDL cholesterol but also HDL cholesterol.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, G-Protein-CoupledCholesterol, HDLScavenger Receptors, Class BHepatocytesProtein Processing, Post-TranslationalCD36 AntigensAnimalsMice, KnockoutHumansUp-RegulationMice, Inbred C57BLMaleCells, CulturedFemaleBiomarkersLiverExtracellular Signal-Regulated MAP KinasesMice

Stichwörter der Autor:innen

G-protein coupled receptorGPR146High-density lipoproteinSR-B1

Substanzen

Receptors, G-Protein-CoupledCholesterol, HDLScarb1 protein, mouseScavenger Receptors, Class BSCARB1 protein, humanCD36 AntigensBiomarkersExtracellular Signal-Regulated MAP Kinases

Autor:innen und Institutionen

  • Department of Pediatrics, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, Groningen 9713 AV, The Netherlands.
  • Nantes Université, CNRS, INSERM, L'institut du Thorax, F-44000 Nantes, France.
  • Department of Medicine, Division of Endocrinology, and Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.
  • LiMitAging, Institute of Metabolic and Cardiovascular Diseases, I2MC UMR1297, IHU HealthAge, INSERM, Université de Toulouse, Toulouse University Hospital (CHU Toulouse), Toulouse, France.
  • Institute of Clinical Chemistry, University Hospital of Zurich and University of Zurich, Zurich, Switzerland.

ORCID-Profile: Boyan Zhang, Federico Oldoni, Arnold von Eckardstein, Umesh Tharehalli

Förderung

  • China Scholarship Council and University Medical Center Groningen
  • Agence Nationale de la Recherche
  • ZonMw
  • European Union
  • ENW NWO
  • Swiss Heart Foundation
  • Swiss National Science Foundation
  • European Atherosclerosis Society

Zitieren

APA

Zhang, B., Loaiza, N., Rimbert, A., Oldoni, F., Blauw, L. L., Rensen, P. C. N., Martinez, L. O., Robert, J., von Eckardstein, A., Wolters, J. C., Huijkman, N., Kloosterhuis, N., Smit, M., van de Sluis, B., Kuivenhoven, J. A., & Tharehalli, U. (2026). Loss of GPR146 decreases plasma levels of HDL cholesterol via post-translational up-regulation of SR-B1 protein levels. Cardiovascular Research. https://doi.org/10.1093/cvr/cvaf254

Vancouver

Zhang B, Loaiza N, Rimbert A, Oldoni F, Blauw LL, Rensen PCN, et al. Loss of GPR146 decreases plasma levels of HDL cholesterol via post-translational up-regulation of SR-B1 protein levels. Cardiovascular Research. 2026. doi:10.1093/cvr/cvaf254

BibTeX
@article{Zhang2026,
  author = {Zhang, Boyan and Loaiza, Natalia and Rimbert, Antoine and Oldoni, Federico and Blauw, Lisanne L and Rensen, Patrick C N and Martinez, Laurent O and Robert, Jerome and von Eckardstein, Arnold and Wolters, Justina Clarinda and Huijkman, Nicolette and Kloosterhuis, Niels and Smit, Marieke and van de Sluis, Bart and Kuivenhoven, Jan Albert and Tharehalli, Umesh},
  title = {Loss of GPR146 decreases plasma levels of HDL cholesterol via post-translational up-regulation of SR-B1 protein levels},
  journal = {Cardiovascular Research},
  year = {2026},
  doi = {10.1093/cvr/cvaf254}
}
Kostenlos starten →